PUBLIC COMPANY
savePATH
updated 4mo ago
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall10 co-mentions · 10 sources
- tagHematology6 co-mentions · 6 sources
- tagAdCom4 co-mentions · 4 sources
- tag510(k) Clearance3 co-mentions · 3 sources
- companyUniversity of Virginia1 co-mentions · 1 sources
- companyUniversity of Washington1 co-mentions · 1 sources
- tagCardiology1 co-mentions · 1 sources
- tagImmunology1 co-mentions · 1 sources
pipeline
1
marketed
0
phase 3
0
catalysts ytd
8
approvals ytd
0
recalls ytd
6
Pipeline(1)
pipeline depth1 products
1Preclinical
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
- phase2Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama
- phase2Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
- phase2Infant Malaria Vaccine Schedule Optimization
- phase3Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls
- phase1Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines
- phase2Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy
🐶 Hiring Signal
News
- Hospital and pharmaceutical prices are smothering America’s businessesWorkers and employers are drowning in their health insurance premiums. The reason for that deluge: the health care industry’s high and inscrutable prices.stat · 1h ago
- STAT+: Are stem cells the next peptides? These advocates think RFK Jr. could make it happenPeptides gained legitimacy at the FDA after being embraced by MAHA. Advocates hope stem cell treatments will follow the same path.stat · 1h ago
- Roivant, the 'inveterate drug hunters', enters commercial era with LisrayaCEO Matt Gline is juggling Roivant Sciences' first solo drug launch and several maturing programs as the hub-and-spoke company sets its sights on a massive turning point into commercial viability.biospace · 6h ago
- Opinion: FDA must ensure American patients can access new and experimental drugsThe FDA has taken important steps through Operation TrialBlazer and stronger scrutiny of foreign clinical data, but more must be done to make the United States more competitive in attracting clinic…biospace · 6h ago
- NIH rolling out streamlined website to help public find information more easilyThe redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to understand NIH's organizational structurestat · 2d ago
- Foghorn cuts 40% of workforceFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 2d ago
- Abbott launches SimpleScreen CRC blood test in the USAbbott is kick-starting the U.S. commercial launch of SimpleScreen CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average risk for th…fiercebiotech · 3d ago
- Lilly, Foghorn part ways; Wave’s FDA-approved plansThe pharma giant cut its partnership after a cancer drug disappointed in testing. Elsewhere, Teva and Samsung Bioepis expanded a partnership and space biotech Varda brought in $251 million.biopharma_dive · 3d ago
- Lawmakers hear mixed opinions on psychedelics credentialingAs psychedelic drugs inch closer to commercialization, two House lawmakers are charting a path forward for their inevitable rollout and what any potential accompanying legislation could focus on. T…endpoints · 3d ago
- FDA starts review of Roche’s multiple sclerosis pillThe FDA previously hadn’t ever accepted an application of a drug like fenebrutinib in two major forms of MS. But safety questions still hang over Roche’s program.biopharma_dive · 4d ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that